ITRM Iterum Therapeutics PLC

0.03079 (4.43%)
Last Updated: 13:42:16
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 30,715
Bid Price 0.7035
Ask Price 0.73
News -
Day High 0.725892


52 Week Range


Day Low 0.67
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03079 4.43% 0.725892 13:42:16
Open Price Low Price High Price Close Price Prev Close
0.69 0.67 0.725892 0.6951
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
90 30,715 $ 0.7134063 $ 21,912 - 0.601098 - 2.0499
Last Trade Time Type Quantity Stock Price Currency
13:42:16 100 $ 0.725892 USD

Iterum Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.47M 13.04M - 503k -43.67M -3.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Iterum Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ITRM Message Board. Create One! See More Posts on ITRM Message Board See More Message Board Posts

Historical ITRM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.73820.7597870.6450.682800714,443-0.01231-1.67%
1 Month0.880.900.6450.771952718,706-0.15411-17.51%
3 Months1.101.260.6451.0038,495-0.37411-34.01%
6 Months0.95891.360.6451.0845,292-0.23301-24.3%
1 Year1.802.04990.6010981.19129,459-1.07-59.67%
3 Years0.63543.13050.1751.325,543,9580.0904914.24%
5 Years6.709.30070.1751.343,414,471-5.97-89.17%

Iterum Therapeutics Description

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.
Your Recent History
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now